These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


773 related items for PubMed ID: 9782579

  • 41. Cyclosporine in severe ulcerative colitis refractory to steroid therapy.
    Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S.
    N Engl J Med; 1994 Jun 30; 330(26):1841-5. PubMed ID: 8196726
    [Abstract] [Full Text] [Related]

  • 42. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
    Zheng JJ, Chu XQ, Shi XH, Zhou CL, Seng BW.
    J Dig Dis; 2008 May 30; 9(2):84-8. PubMed ID: 18419641
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J, Grancher K, Mandel F, Daum F.
    Am J Gastroenterol; 1993 Jan 30; 88(1):44-8. PubMed ID: 8420272
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. [Cyclosporine treatment of patients with active ulcerative colitis refractory to high-dose glucocorticoid].
    Kjeldsen J, Wilson BV, Knudsen T.
    Ugeskr Laeger; 2001 Jan 01; 163(1):22-5. PubMed ID: 11586667
    [Abstract] [Full Text] [Related]

  • 47. Low-dose oral microemulsion ciclosporin for severe, refractory ulcerative colitis.
    de Saussure P, Soravia C, Morel P, Hadengue A.
    Aliment Pharmacol Ther; 2005 Aug 01; 22(3):203-8. PubMed ID: 16091057
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. [Current therapeutic possibilities in chronic inflammatory intestinal diseases].
    Schölmerich J.
    Praxis (Bern 1994); 1995 Jan 10; 84(2):29-33. PubMed ID: 7839043
    [Abstract] [Full Text] [Related]

  • 51. Cyclosporin for the treatment of severe ulcerative colitis.
    Wenzl H, Petritsch W, Reicht G, Eherer A, Krejs GJ.
    Z Gastroenterol; 1994 Mar 10; 32(3):137-40. PubMed ID: 8197807
    [Abstract] [Full Text] [Related]

  • 52. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C, Beau P.
    Gastroenterol Clin Biol; 2008 Feb 10; 32(2):153-7. PubMed ID: 18343615
    [Abstract] [Full Text] [Related]

  • 53. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
    Mantzaris GJ, Sfakianakis M, Archavlis E, Petraki K, Christidou A, Karagiannidis A, Triadaphyllou G.
    Am J Gastroenterol; 2004 Jun 10; 99(6):1122-8. PubMed ID: 15180735
    [Abstract] [Full Text] [Related]

  • 54. Cyclosporin for severe ulcerative colitis: a user's guide.
    Kornbluth A, Present DH, Lichtiger S, Hanauer S.
    Am J Gastroenterol; 1997 Sep 10; 92(9):1424-8. PubMed ID: 9317057
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [Efficacy and safety of cyclosporine in the treatment of inflammatory bowel disease in children - a retrospective study].
    Socha P, Wawer Z, Ryzko J, Orłowska E, Szczepański M, Kierkus J, Celińska-Cedro D, Socha J.
    Med Wieku Rozwoj; 2006 Sep 10; 10(2):429-35. PubMed ID: 16825713
    [Abstract] [Full Text] [Related]

  • 57. Factors affecting the efficacy of cyclosporin A therapy for refractory ulcerative colitis.
    Bamba S, Tsujikawa T, Inatomi O, Nakahara T, Koizumi Y, Saitoh Y, Sasaki M, Fujiyama Y, Andoh A.
    J Gastroenterol Hepatol; 2010 Mar 10; 25(3):494-8. PubMed ID: 20370728
    [Abstract] [Full Text] [Related]

  • 58. [Cyclosporin for severe ulcerative colitis].
    Symon Z, Stalnikowich R, Eliakim R, Ackerman Z, Rachmilewitz D.
    Harefuah; 1997 Jan 15; 132(2):77-80, 152. PubMed ID: 9119304
    [Abstract] [Full Text] [Related]

  • 59. Management of varicella infection during the course of inflammatory bowel disease.
    Mouzas IA, Greenstein AJ, Giannadaki E, Balasubramanian S, Manousos ON, Sachar DB.
    Am J Gastroenterol; 1997 Sep 15; 92(9):1534-7. PubMed ID: 9317080
    [Abstract] [Full Text] [Related]

  • 60. Pharmacotherapy of inflammatory bowel disease.
    Gardner RC.
    Am J Hosp Pharm; 1976 Aug 15; 33(8):831-8. PubMed ID: 782236
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 39.